Guest guest Posted October 6, 2003 Report Share Posted October 6, 2003 To be simplistic as far as the Food and Drug Administration goes, if it's a food then you would prove harm to be banned, drugs have to prove there is no harm in its use. The trade-off is that we continue to lose out on that elusive insurance money and the use of herbs in hospitals. doug > > In other words, as soon as one embraces a scientific approach to the > problem of iatrogenesis from CHM, a multitude of problematic issues > arise. There is considerable risk in all this that herbs will be > banned or their use restricted beyond a level that we would consider > to be appropriate, there would be strong pressure for CM to define > itself in line with the type of scientific research that was being > conducted. etc. And where would the funds for all this research come > from? When a new drug is licensed, a high percentage of the > development costs (which may be in the region of $300,000,000) go into > clinical trials. > > This is a very complex area, and that if we wish Chinese medicine as > we know it to survive, an important task is for us to exert political > pressure to NOT subject CM to any type of systematic scientific > investigation, or at the very least, to preserve a high measure of > autonomy for CM in the process. > > > > Wainwright Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 6, 2003 Report Share Posted October 6, 2003 To be simplistic as far as the Food and Drug Administration goes, if it's a food then you would prove harm to be banned, drugs have to prove there is no harm in its use. The trade-off is that we continue to lose out on that elusive insurance money and the use of herbs in hospitals. doug >>>No foods must be shown to have no toxic effects, drugs can have them alon Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 6, 2003 Report Share Posted October 6, 2003 Doug, You lose out on more than insurance money. You lose out on the opportunity to spend $500 million per herb or formula to develop " new drug " status. Wainwright was being overly modest in his estimates. Since there's no possibility of patents, then who ever makes the investment will be doing so purely as a public service. Any volunteers? Emmanuel Segmen To be simplistic as far as the Food and Drug Administration goes, if it's a food then you would prove harm to be banned, drugs have to prove there is no harm in its use. The trade-off is that we continue to lose out on that elusive insurance money and the use of herbs in hospitals. doug > > In other words, as soon as one embraces a scientific approach to the > problem of iatrogenesis from CHM, a multitude of problematic issues > arise. There is considerable risk in all this that herbs will be > banned or their use restricted beyond a level that we would consider > to be appropriate, there would be strong pressure for CM to define > itself in line with the type of scientific research that was being > conducted. etc. And where would the funds for all this research come > from? When a new drug is licensed, a high percentage of the > development costs (which may be in the region of $300,000,000) go into > clinical trials. > > This is a very complex area, and that if we wish Chinese medicine as > we know it to survive, an important task is for us to exert political > pressure to NOT subject CM to any type of systematic scientific > investigation, or at the very least, to preserve a high measure of > autonomy for CM in the process. > > > > Wainwright Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 7, 2003 Report Share Posted October 7, 2003 Emmanuel, Gees, has the price of an IND dropped so low? I researched the herbal medicine/FDA interface from top to bottom for a Chinese traditional pharmaceutical company back in 96/97 and an IND could easily cost $1 billion back then. Ken , " Emmanuel Segmen " < susegmen@i...> wrote: > Doug, > > You lose out on more than insurance money. You lose out on the opportunity to spend $500 million per herb or formula to develop " new drug " status. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.